Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul 25:4:11.
doi: 10.3389/fnmol.2011.00011. eCollection 2011.

The role of insulin-like growth factor-I in the physiopathology of hearing

Affiliations

The role of insulin-like growth factor-I in the physiopathology of hearing

Silvia Murillo-Cuesta et al. Front Mol Neurosci. .

Abstract

Insulin-like growth factor-I (IGF-I) belongs to the family of polypeptides of insulin, which play a central role in embryonic development and adult nervous system homeostasis by endocrine, autocrine, and paracrine mechanisms. IGF-I is fundamental for the regulation of cochlear development, growth, and differentiation, and its mutations are associated with hearing loss in mice and men. Low levels of IGF-I have been shown to correlate with different human syndromes showing hearing loss and with presbyacusis. Animal models are fundamental to understand the genetic, epigenetic, and environmental factors that contribute to human hearing loss. In the mouse, IGF-I serum levels decrease with aging and there is a concomitant hearing loss and retinal degeneration. In the Igf1(-/-) null mouse, hearing loss is due to neuronal loss, poor innervation of the sensory hair cells, and age-related stria vascularis alterations. In the inner ear, IGF-I actions are mediated by intracellular signaling networks, RAF, AKT, and p38 MAPK protein kinases modulate the expression and activity of transcription factors, as AP1, MEF2, FoxM1, and FoxP3, leading to the regulation of cell cycle and metabolism. Therapy with rhIGF-I has been approved in humans for the treatment of poor linear growth and certain neurodegenerative diseases. This review will discuss these findings and their implications in new IGF-I-based treatments for the protection or repair of hearing loss.

Keywords: IGF1R signaling; animal models; deafness; human genetics; insulin-like factors; organ of Corti.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Insulin-like growth factor system.
Figure 2
Figure 2
Insulin-like growth factor-I signaling.
Figure 3
Figure 3
Main features of the neural (A) and cochlear (B) phenotype of the Igf1−/− null mouse. Data have been compiled from Liu et al. (1993), Beck et al. (1995), Cheng et al. (1998), Gao et al. (1999), Camarero et al. (2001, 2002), Ye et al. (2002a,b), Cediel et al. (2006), Sullivan et al. (2008), Riquelme et al. (2010).

Similar articles

Cited by

References

    1. Adams T. E., Epa V. C., Garrett T. P., Ward C. W. (2000). Structure and function of the type 1 insulin-like growth factor receptor. Cell. Mol. Life Sci. 57, 1050–109310.1007/PL00000744 - DOI - PMC - PubMed
    1. Annunziata M., Granata R., Ghigo E. (2010). The IGF system. Acta Diabetol. 48, 1–910.1007/s00592-010-0227-z - DOI - PubMed
    1. Baker J., Liu J. P., Robertson E. J., Efstratiadis A. (1993). Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73–8210.1016/S0092-8674(05)80085-6 - DOI - PubMed
    1. Barrenas M., Landin-Wilhelmsen K., Hanson C. (2000). Ear and hearing in relation to genotype and growth in Turner syndrome. Hear. Res. 144, 21–2810.1016/S0378-5955(00)00040-X - DOI - PubMed
    1. Barrenas M. L., Bratthall A., Dahlgren J. (2005). The association between short stature and sensorineural hearing loss. Hear. Res. 205, 123–13010.1016/j.heares.2005.03.019 - DOI - PubMed